Feasibility and Effectiveness - MAP Online Program - Emerging Adults - Phase II |
IVD in colon cancer |
Prebiotics and prebiotics in the treatment of type 2 diabetes |
Nasal recombinant human interferon alfa-2b in ARI |
Jusvinza in Severe Patients with Acquired Community Pneumonia |
NeuroEPO in mild-moderate Alzheimer's disease amnesic variant |
NeuroEPO in mild-moderate Alzheimer's disease |
Sinopharm-SOBERANA COVID-Cienfuegos |
Nasalferon in ARI |
Effect of dietary fiber consumption on health |
Evaluation of Clinical Performance of INFANTIX in a Maternity Hospital |
Jusvinza in rheumatoid arthritis |
NUTRIRES2 |
Post EUA study of Itolizumab in COVID-19 |
Antioxidant efcts of Abexol in middle-aged and older subjects |
VALIDATION OF AUTOMATIC DEVICES IN THE CLINIC: VALIDAC-1 |
Nasalferon in COVID-19 |
BACONAO Study |
SOBERANA PLUS TURIN |
Expanded Clinical Use of Nasalferon in COVID-19 |